PEDRETTI, ROBERTO FRANCO ENRICO
 Distribuzione geografica
Continente #
AS - Asia 8.360
NA - Nord America 2.245
EU - Europa 1.996
SA - Sud America 827
AF - Africa 129
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.605
Nazione #
SG - Singapore 3.722
US - Stati Uniti d'America 2.068
VN - Vietnam 1.993
CN - Cina 1.006
HK - Hong Kong 758
BR - Brasile 595
IT - Italia 558
RU - Federazione Russa 302
FR - Francia 176
KR - Corea 155
DE - Germania 150
ES - Italia 135
IN - India 118
MX - Messico 103
GB - Regno Unito 94
TR - Turchia 87
ID - Indonesia 85
BD - Bangladesh 80
NL - Olanda 77
FI - Finlandia 76
AR - Argentina 73
PT - Portogallo 71
CO - Colombia 70
IE - Irlanda 61
CA - Canada 55
IQ - Iraq 49
JP - Giappone 47
AT - Austria 45
AU - Australia 40
ZA - Sudafrica 39
BE - Belgio 38
PK - Pakistan 37
PL - Polonia 30
SA - Arabia Saudita 29
UA - Ucraina 27
SE - Svezia 26
PH - Filippine 24
MY - Malesia 23
TW - Taiwan 23
EC - Ecuador 22
UZ - Uzbekistan 21
CL - Cile 19
EG - Egitto 18
HU - Ungheria 18
MA - Marocco 17
KE - Kenya 15
CH - Svizzera 13
NO - Norvegia 13
PY - Paraguay 13
VE - Venezuela 13
GR - Grecia 12
JO - Giordania 12
RO - Romania 12
TH - Thailandia 11
IL - Israele 10
AZ - Azerbaigian 9
BO - Bolivia 9
ET - Etiopia 9
LT - Lituania 9
CZ - Repubblica Ceca 8
RS - Serbia 8
SY - Repubblica araba siriana 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
NZ - Nuova Zelanda 7
HR - Croazia 6
LU - Lussemburgo 6
OM - Oman 6
SI - Slovenia 6
UY - Uruguay 6
AL - Albania 5
CR - Costa Rica 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
JM - Giamaica 4
NG - Nigeria 4
QA - Qatar 4
BG - Bulgaria 3
DZ - Algeria 3
MN - Mongolia 3
NI - Nicaragua 3
SN - Senegal 3
BH - Bahrain 2
GE - Georgia 2
IR - Iran 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
PA - Panama 2
PS - Palestinian Territory 2
SC - Seychelles 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BW - Botswana 1
BY - Bielorussia 1
Totale 13.586
Città #
Hong Kong 738
Singapore 662
Hanoi 615
Ho Chi Minh City 611
San Jose 471
Hefei 350
Ashburn 233
Seoul 151
Beijing 124
The Dalles 104
Chicago 99
Milan 92
New York 82
Lauterbourg 77
Da Nang 76
Los Angeles 74
Ann Arbor 73
São Paulo 66
Dallas 64
Moscow 56
Jakarta 54
Frankfurt am Main 51
Helsinki 51
Council Bluffs 48
Buffalo 47
Quận Bình Thạnh 47
Haiphong 42
Dublin 37
Biên Hòa 36
Hải Dương 34
Santa Clara 33
Vũng Tàu 33
Brasília 32
Fairfield 32
Naples 31
Ninh Bình 31
Rome 29
Nuremberg 28
Istanbul 25
Vienna 25
Houston 24
Rio de Janeiro 24
Baghdad 23
Porto 23
Amsterdam 22
Shanghai 22
Bogotá 21
Galway 21
Mexico City 21
Quận Phú Nhuận 21
Sydney 21
Thái Nguyên 21
Belo Horizonte 20
Dhaka 20
Quận Một 20
Lisbon 19
Can Tho 18
Toronto 18
Barcelona 17
Quận Bảy 17
Tashkent 17
Tokyo 17
Bologna 16
Bắc Ninh 16
Ha Long 16
Phoenix 16
Redondo Beach 16
Wilmington 16
Brussels 14
Lappeenranta 14
Medellín 14
Porto Alegre 14
Princeton 14
Catania 13
Chennai 13
Curitiba 13
Hangzhou 13
Paris 13
Quận Bốn 13
Seattle 13
Warsaw 13
Woodbridge 13
Boardman 12
Buenos Aires 12
Florence 12
Lahore 12
Madrid 12
Nairobi 12
Nam Định 12
Santiago 12
Zhengzhou 12
Ottawa 11
Amman 10
Ankara 10
Atlanta 10
Bangkok 10
Brisbane 10
Budapest 10
Chandler 10
Kuala Lumpur 10
Totale 6.493
Nome #
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: Why and how: A position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology 1.569
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology 1.345
Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy? 376
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 342
2023 ESC Guidelines for the management of acute coronary syndromes 288
Shortened questionnaires to assess anxiety and depression during in-hospital rehabilitation: Clinical validation and cutoff scores 270
Documento di consenso intersocietario ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: La terapia antiaggregante a lungo termine nel paziente con malattia coronarica 259
Best practice in psychological activities in cardiovascular prevention and rehabilitation: Position Paper 258
Patients submitted for percutaneous coronary intervention: Pathways for prognostic stratification and multidisciplinary management with respect to the risk profile 241
LV Strain Superiority Over LVEF in HFmrEF: Is the Job Done After David's Victory Over Goliath? 239
The rehabilitation phase 237
Regular Wine Consumption in Chronic Heart Failure: Impact on Outcomes, Quality of Life, and Circulating Biomarkers 217
Heart rate as a therapeutic target after acute coronary syndrome and in chronic coronary heart disease 213
Prospective use of microvolt T-wave alternans testing to guide primary prevention implantable cardioverter defibrillator therapy 213
Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease 211
Characteristics of structured physical training currently provided in cardiac patients: insights from the Exercise Training in Cardiac Rehabilitation (ETCR) Italian survey 211
Chronicity and aging in cardiology: Geriatric cardiology, cardiac rehabilitation or care-related cardiogeriatric rehabilitation? 208
Effects of an outpatient service rehabilitation programme in patients affected by pulmonary arterial hypertension: An observational study 208
Evolving determinants of carotid atherosclerosis vulnerability in asymptomatic patients from the MAGNETIC observational study 208
Components of arterial systolic pressure and RR-interval oscillation spectra in a case of baroreflex failure, a human open-loop model of vascular control 207
Cardiac rehabilitation activities during the COVID-19 pandemic in Italy. Position paper of the AICPR (Italian Association of Clinical Cardiology, Prevention and Rehabilitation) 194
Acute LDL-C reduction post ACS: strike early and strike strong: From evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy 186
2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC) 186
2023 ESC Guidelines for the management of acute coronary syndromes 178
2023 ESC Guidelines for the management of acute coronary syndromes 168
Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies? 162
Web discussions on cardiovascular diseases: pre-COVID-19 evaluation and impact of the COVID-19 pandemic – Web listening analysis in the Italian population 155
ANMCO/GISE/SICOA Consensus document: Role of coronary computed tomography angiography in chronic coronary syndromes 140
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 140
Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis 133
Epigenetics in the primary and secondary prevention of cardiovascular disease: influence of exercise and nutrition 132
Better adherence with out-of-hospital healthcare improved long-term prognosis of acute coronary syndromes: Evidence from an Italian real-world investigation 130
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 129
Mediterranean diet impact on cardiovascular diseases: A narrative review 129
Referral from vascular surgery to cardiovascular rehabilitation and related outcomes in patients with peripheral arterial disease: The THINKPAD-RELOADED survey 126
null 124
Measuring change in rehabilitative cardiology: Reliability of a short questionnaire to assess an outcome 117
Introducing the new Task Force on Cardiovascular Risk Factors of the European Association of Preventive Cardiology 117
Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going 115
The Role of Multiple Mutations in Hypertrophic Cardiomyopathy-A New Universe to Discover: Proof of Guiltiness of the Genetic Burden in Worsening Hypertrophic Cardiomyopathy Natural History 114
Standardised Exercise Prescription for Patients with Chronic Coronary Syndrome and/or Heart Failure: A Consensus Statement from the EXPERT Working Group 114
Predictors of survival in patients undergoing cardiac rehabilitation after transcatheter aortic valve replacement (TAVR): a multicenter retrospective study 110
Overall adherence to treatment in the continuum of cardiovascular prevention 108
Assessment of on-site and remote cardiac rehabilitation in romania 108
Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018 [Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 104
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation 103
Cardiac prevention and rehabilitation “3.0”: from acute to chronic phase. Position paper of the ltalian association for cardiovascular prevention and rehabilitation (GICR-IACPR) 103
ICAROS (Italian survey on CardiAc RehabilitatiOn and Secondary prevention after cardiac revascularization): Temporary report of the first prospective, longitudinal registry of the cardiac rehabilitation network GICR/IACPR 103
A Multidisciplinary Consensus Document on Follow-Up Strategies for Patients Treated With Percutaneous Coronary Intervention 102
Erectile dysfunction and cardiovascular disease: focus on 101
HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence 96
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology 90
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 88
Modes of death and prognostic outliers in chronic heart failure 88
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: A consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA) 87
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry 87
The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology 87
Cardiac rehabilitation in heart failure after the ExTraMATCH II study: who still believes? 85
Management and prescription of physical activity/physical training 82
What constitutes the ‘Minimal Care’ interventions of the nurse, physiotherapist, dietician and psychologist in Cardiovascular Rehabilitation and secondary prevention: A position paper from the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiology 82
Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group 80
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: A consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA) 79
Antenatal, perinatal, and primordial cardiovascular prevention: What is known, what is happening, and future directions 78
Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper 76
Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey 75
Cardiac rehabilitation in Europe: Where we are and where we are going 74
Nonsteroid anti-inflammatory drugs (NSAID) and risk of cardiovascular events. Literature review and clinical implications 73
Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score 72
Impact of in-hospital cardiac rehabilitation on mortality and readmissions in heart failure: A population study in Lombardy, Italy, from 2005 to 2012 72
Current activities of Cardiovascular Rehabilitation in the ambulatory setting of the Lombardy Region [Cardiologia Riabilitativa e macroattività ambulatoriali complesse in Regione Lombardia] 69
Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death 68
Exercise-based cardiac rehabilitation in cardiac resynchronization therapy recipients: A primer for practicing clinicians 67
Linking the ICF codes to clinical real-ufe assessments: The challenge of the transition from theory to practice 67
Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: Impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry 65
A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification 64
How to define the relative contraindications to oral anticoagulant therapy 63
Cardiac Prevention and Rehabilitation "3.0": From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR) [La Cardiologia Preventiva e Riabilitativa "3.0": Dalle acuzie alla cronicità. Position paper del Gruppo Italiano di Cardiologia Riabilitativa e Preventiva (GICR-IACPR)] 62
Cardio-respiratory international classification of functioning, disability and health sets for inpatient rehabilitation: From theory to practice 61
Preoperative n-3 polyunsatured fatty acids are associated with a decrease in the incidence of early atrial fibrillation following cardiac surgery 61
Gestione ambulatoriale del paziente di interesse cardiologico: ruolo del medico di medicina generale e del cardiologo, tra sostenibilità ed appropriatezza 61
Altered fasting glycemia in cardiac patients during in-hospital rehabilitation: Impact on short and long-term follow-up 60
Right ventricular pressure changes during induced ventricular tachycardias predict clinical symptoms of cerebral hypoperfusion: Implications for a reduction of unnecessary, painful ICD shocks 59
Presentation 58
From geriatric cardiology to ‘cardio-geriatric’ prevention and rehabilitation: Need for a new core curriculum? 58
Structure and functional organization of Arrhythmology [Struttura e organizzazione funzionale dell'Aritmologia] 54
Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era 47
Prevention of sudden death in patients with heart failure: Cardiac resynchronization therapy with or without back-up defibrillation 46
Totale 13.892
Categoria #
all - tutte 31.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 14 22
2021/2022118 11 9 18 14 9 9 2 2 6 7 17 14
2022/202373 10 27 5 2 3 13 0 6 6 0 0 1
2023/202485 4 1 0 3 16 16 13 0 8 0 16 8
2024/20256.702 15 27 9 15 329 83 341 196 434 529 1.800 2.924
2025/20266.678 890 896 482 676 520 334 934 416 607 717 206 0
Totale 13.892